{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:03Z","timestamp":1789001223658,"version":"build-2803163510"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The presence of bridging fibrosis predicts survival of primary biliary cholangitis (PBC). This study aimed to compare serum parameters for the estimation of liver fibrosis and prediction of clinical outcomes in PBC.<\/jats:p>\n                    <jats:p>Out of 392 patients with PBC, 102 who underwent liver biopsy and in whom fibrosis indices, platelet count, hyaluronic acid, type IV collagen 7\u200asecond domain, procollagen type III amino-terminal peptide, tissue inhibitor of metalloproteinases 1, Mac-2 binding protein glycosylation isomer, N-terminal type III collagen propeptide levels; fibrosis index based on 4 factors, aspartate aminotransferase-to-platelet ratio index, and enhanced liver fibrosis (ELF) score were determined, were included. The correlation of histological stages based on both Scheuer and Nakanuma classifications with fibrosis indices was investigated. The Nakanuma system comprises grading for liver fibrosis and bile duct loss. Diagnostic performances of 10 fibrosis indices were evaluated to identify patients with poor prognosis. Moreover, correlations of those with PBC clinical manifestation and survival were also investigated.<\/jats:p>\n                    <jats:p>Enhances liver fibrosis (ELF) score had the highest correlation coefficient for liver fibrosis evaluated according to either the Scheuer or Nakanuma classification among 10 serum fibrosis indices. It also had the highest diagnostic performance in estimating Scheuer stage III and Nakanuma fibrosis score 2, both of which represent portal-bridging fibrosis. Patients with an ELF score of \u226510.0 had shorter survival and presented more frequently clinical complications than those with an ELF score of &lt;10.0.<\/jats:p>\n                    <jats:p>ELF score determines the severity of liver fibrosis and predicts the occurrence of complications and survival in patients with PBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000027403","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T15:28:24Z","timestamp":1633102104000},"page":"e27403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis"],"prefix":"10.1097","volume":"100","author":[{"given":"Yukihisa","family":"Fujinaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Namisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumimasa","family":"Tomooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotetsu","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ozutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihisa","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Kawaratani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemi","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Mitoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/hepr.13584","article-title":"The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis","volume":"51","author":"Kawata","year":"2020","journal-title":"Hepatol Res"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/hepr.13291","article-title":"Changes in serum levels of leucine-rich alpha2-glycoprotein predict prognosis in primary biliary cholangitis","volume":"49","author":"Hayashi","year":"2019","journal-title":"Hepatol Res"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/hepr.13593","article-title":"The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis","volume":"51","author":"Namisaki","year":"2020","journal-title":"Hepatol Res"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/hepr.13568","article-title":"Serum Gas6 and Axl as non-invasive biomarkers of advanced histological stage in primary biliary cholangitis","volume":"50","author":"Hayashi","year":"2020","journal-title":"Hepatol Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/hepr.13586","article-title":"Changes in disease characteristics of primary biliary cholangitis: an observational retrospective study from 1982 to 2016","volume":"51","author":"Takamura","year":"2020","journal-title":"Hepatol Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2006.07.006","article-title":"International fibrosis group meeting participants. Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group","volume":"4","author":"McHutchison","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02900712","article-title":"Biochemical markers of hepatic fibrosis in primary biliary cirrhosis","volume":"20","author":"Plebani","year":"1990","journal-title":"Ric Clin Lab"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2010.10.002","article-title":"Serum surrogate markers of liver fibrosis in primary biliary cirrhosis","volume":"22","author":"Voumvouraki","year":"2011","journal-title":"Eur J Intern Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1478-3231.2008.01722.x","article-title":"Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy","volume":"28","author":"Farkkila","year":"2008","journal-title":"Liver Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.3748\/wjg.v22.i22.5276","article-title":"Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","article-title":"Serum wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis","volume":"110","author":"Umemura","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1038\/s41598-018-26531-0","article-title":"Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis","volume":"8","author":"Joshita","year":"2018","journal-title":"Sci Rep"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hepr.12595","article-title":"Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-gamma-inducible protein-10 in primary biliary cirrhosis","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MCG.0000000000001433","article-title":"Liver stiffness measured by either magnetic resonance or transient elastography is associated with liver fibrosis and is an independent predictor of outcomes among patients with primary biliary cholangitis","volume":"55","author":"Osman","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-230X-10-103","article-title":"Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis","volume":"10","author":"Friedrich-Rust","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum Pathol"},{"key":"R20-20250504","first-page":"71","article-title":"Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan","volume":"44 Suppl S1","year":"2014","journal-title":"Hepatol Res"},{"key":"R21-20250504","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1159\/000354513","article-title":"Factors involved in extracellular matrix turnover in human derived cardiomyocytes","volume":"32","author":"Casals","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/0009-8981(84)90254-7","article-title":"7\u200aS collagen: a method for the measurement of serum concentrations in man","volume":"144","author":"Hogemann","year":"1984","journal-title":"Clin Chim Acta"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3343\/alm.2018.38.4.348","article-title":"Diagnosis of liver fibrosis with wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) among chronic hepatitis B patients","volume":"38","author":"Jekarl","year":"2018","journal-title":"Ann Lab Med"},{"key":"R26-20250504","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1309\/W3XCNT4HKFBN2G0B","article-title":"A systematic review of the quality of liver biopsy specimens","volume":"125","author":"Cholongitas","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1111\/hepr.12746","article-title":"Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis","volume":"47","author":"Namisaki","year":"2017","journal-title":"Hepatol Res"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/hepr.13355","article-title":"Identification of clinical risk factors for histological progression of primary biliary cholangitis","volume":"49","author":"Fujinaga","year":"2019","journal-title":"Hepatol Res"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e0131658","DOI":"10.1371\/journal.pone.0131658","article-title":"Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis","volume":"10","author":"Sekiguchi","year":"2015","journal-title":"PLoS One"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"i4428","DOI":"10.1136\/bmj.i4428","article-title":"Guideline Development Group. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.cgh.2020.06.070","article-title":"Enhanced liver fibrosis score can be used to predict liver-related events in patients with nonalcoholic steatohepatitis and compensated cirrhosis","volume":"19","author":"Are","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jvh.12161","article-title":"Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection","volume":"21","author":"Trembling","year":"2014","journal-title":"J Viral Hepat"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2893.2009.01263.x","article-title":"Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","volume":"18","author":"Parkes","year":"2011","journal-title":"J Viral Hepat"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/hepr.13495","article-title":"Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"50","author":"Inadomi","year":"2020","journal-title":"Hepatol Res"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.30842","article-title":"Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials","volume":"70","author":"Anstee","year":"2019","journal-title":"Hepatology"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2008.07.039","article-title":"Exceeding the limits of liver histology markers","volume":"50","author":"Mehta","year":"2009","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:12:04Z","timestamp":1746321124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":40,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027403","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"2021-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}